Cannabidiol (CBD) is one of the ingredients in the cannabis plant that contains little or no tetrahydrocannabinol (THC). There is emerging research that CBD may reduce symptoms of schizophrenia, but a person should not use the compound as an alternative to medical treatment.
Emerging research suggests that it may reduce some symptoms of schizophrenia. However, it is not a substitute for medical treatment, and
Cannabidiol is one of the ingredients in cannabis. CBD oil contains little or no tetrahydrocannabinol (THC). THC is the psychoactive ingredient in cannabis that causes euphoria, or a “high.”
While the research on CBD for schizophrenia shows promise, many studies are very small or low quality. Additionally, no research has shown that CBD can cure schizophrenia or that it is a better treatment method than antipsychotics.
It is important to treat schizophrenia with the remedies a doctor recommends, such as antipsychotics, to prevent the condition from worsening — and to improve long-term outcomes. If a person wishes to try supplementing their treatment with CBD, it is important to first discuss this with a doctor.
This article discusses the research behind CBD oil and schizophrenia, the potential benefits and risks of using this compound, and other alternative treatments.
Is CBD legal?The 2018 Farm Bill removed hemp from the legal definition of marijuana in…
